InsidersTradesSigma
Carasent AB Stock: price and directors' dealings · Finland · FIN-FSA
Track the Carasent AB stock price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Carasent AB has logged 3 insider filings. Market capitalisation: €1.5bn. The latest transaction was filed on 28 May 2026 (Purchase). Among the most active insiders: Johan Kallblad. Every trade is openly available.
3
Insider Decl.
0
Thresholds
€68,594
3 ops.
Buy Volume
·
0 ops.
Sell Volume
26Σ signal
Fundamental score
Ranked 11,106 of 25,927 companies
55.6
score / 100
Value39
Quality72
FCF yld-0.0%
Earn yld2.3%
EV/EBITDA16.1x
ROE4.9%
Gross mgn84%
Net mgn10%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 28 May 2026
Declarations3 total
20,000 shares@ €2.16860.0028% mcap64.0% of flowAktieFI:A003Z291-1
Ideal exit: 22 Feb 2027 (T+270)
10,000 shares@ €2.44250.0016% mcap100.0% of flowAktieFI:A003U605-1
Ideal exit: 7 Sept 2026 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
396 shares@ €2.00990.0001% mcap100.0% of flowAktieFI:A003M446-1
Ideal exit: 5 Dec 2025 (T+270)
3 of 3 declarations